Complexation of Z-ligustilide with hydroxypropyl-β-cyclodextrin to improve stability and oral bioavailability

1. H. Y. Peng, J. R. Du, G. Y. Zhang, X. Kuang, Y. X. Liu, Z. M. Qian and C. Y. Wang, Neuroprotective effect of Z-ligustilide against permanent focal ischemic damage in rats, Biol. Pharm. Bull. 30 (2007) 309-312; DOI: JST.JSTAGE/bpb/30.309 [pii].10.1248/bpb.30.309Search in Google Scholar

2. J. Sun, B. K. Tan, S. H. Huang, M. Whiteman and Y. Z. Zhu, Effects of natural products on ischemic heart diseases and cardiovascular system, Acta Pharmacol. Sin. 23(2002) 1142-1151.Search in Google Scholar

3. J. Y. Zhan, K. Y. Zheng, K. Y. Zhu, C. W. Bi, W. L. Zhang, C. Y. Du, Q. Fu, T. T. Dong, R. C. Choi, K. W. Tsim and D. T. Lau, Chemical and biological assessment of Angelicae Sinensis Radix after processing with wine: an orthogonal array design to reveal the optimized conditions, J. Agric Food Chem. 59 (2011) 6091-6098; DOI: 10.1021/jf200728e.10.1021/jf200728eSearch in Google Scholar

4. K. Y. Zheng, R. C. Choi, A. W. Cheung, A. J. Guo, C. W. Bi, K. Y. Zhu, Q. Fu, Y. Du, W. L. Zhang, J. Y. Zhan, R. Duan, D. T. Lau, T. T. Dong and K. W. Tsim, Flavonoids from Radix Astragali induce the expression of erythropoietin in cultured cells: a signaling mediated via the accumulation of hypoxia-inducible factor-1alpha, J. Agric. Food Chem. 59 (2011) 1697-1704; DOI: 10.1021/ jf104018u.Search in Google Scholar

5. X. M. Wu, Z. M. Qian, L. Zhu, F. Du, W. H. Yung, Q. Gong and Y. Ke, Neuroprotective effect of ligustilide against ischemia-reperfusion injury via up-regulation of erythropoietin and down- -regulation of RTP801, Br. J. Pharmacol. 164 (2011) 332-343; DOI: 10.1111/j.1476-5381.2011. 01337.x.Search in Google Scholar

6. X. Kuang, J. R. Du, Y. X. Liu, G. Y. Zhang and H. Y. Peng, Postischemic administration of Z-ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats, Pharmacol. Biochem. Behav. 88 (2008) 213-221; DOI: 10.1016/j.pbb.2007. 08.006.Search in Google Scholar

7. X. Kuang, J. R. Du, Y. S. Chen, J. Wang and Y. N. Wang, Protective effect of Z-ligustilide against amyloid beta-induced neurotoxicity is associated with decreased pro-inflammatory markers in rat brains, Pharmacol. Biochem. Behav. 92 (2009) 635-641; DOI: 10.1016/j.pbb.2009.03.007.10.1016/j.pbb.2009.03.007Search in Google Scholar

8. F. Cui, L. Feng and J. Hu, Factors affecting stability of z-ligustilide in the volatile oil of radix angelicae sinensis and ligusticum chuanxiong and its stability prediction, Drug Dev. Ind. Pharm. 32 (2006) 747-755; DOI: 10.1080/03639040500529101.10.1080/03639040500529101Search in Google Scholar

9. S. Pinnamaneni, N. G. Das and S. K. Das, Formulation approaches for orally administered poorly soluble drugs, Pharmazie 57 (2002) 291-300.Search in Google Scholar

10. J. Szejtli, Introduction and general overview of cyclodextrin chemistry, Chem. Rev. 98 (1998) 1743-1754; DOI: cr970022c [pii].10.1021/cr970022cSearch in Google Scholar

11. L. Szente and J. Szejtli, Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development, Adv. Drug Deliv. Rev. 36 (1999) 17-28; DOI: S0169-409X(98)00092-1 [pii].10.1016/S0169-409X(98)00092-1Search in Google Scholar

12. S. Gould and R. C. Scott, 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review, Food Chem. Toxicol. 43 (2005) 1451-1459; DOI: 10.1016/j.fct.2005.03.007.10.1016/j.fct.2005.03.00716018907Search in Google Scholar

13. G. E. Granero, M. M. Maitre, C. Garnero and M. R. Longhi, Synthesis, characterization and in vitro release studies of a new acetazolamide-HP-beta-CD-TEA inclusion complex, Eur. J. Med. Chem. 43 (2008) 464-470; DOI: 10.1016/j.ejmech.2007.03.037.10.1016/j.ejmech.2007.03.03717544174Search in Google Scholar

14. B. Yang, J. Lin, Y. Chen and Y. Liu, Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode, Bioorg. Med. Chem. 17 (2009) 6311-6317; DOI: 10.1016/j.bmc.2009.07.060.10.1016/j.bmc.2009.07.06019665897Search in Google Scholar

15. C. Yuan, Z. Y. Jin, X. M. Xu, H. N. Zhuang and W. Y. Shen, Preparation and stability of the inclusion complex of astaxanthin with hydroxypropyl-beta-cyclodextrin, Food Chem. 109 (2008) 264-268; DOI: 10.1016/j.foodchem.2007.07.051.10.1016/j.foodchem.2007.07.05126003346Search in Google Scholar

16. Y. Yu, J. R. Du, C. Y. Wang and Z. M. Qian, Protection against hydrogen peroxide-induced injury by Z-ligustilide in PC12 cells, Exp. Brain Res. 184 (2008) 307-312; DOI: 10.1007/s00221-007- -1100-3.Search in Google Scholar

17. Q. F. Zhang, Z. T. Jiang, Y. X. Guo and R. Li, Complexation study of brilliant cresyl blue with beta-cyclodextrin and its derivatives by UV-vis and fluorospectrometry, Spectrochim. Acta A Mol. Biomol. Spectrosc. 69 (2008) 65-70; DOI: 10.1016/j.saa.2007.03.009.10.1016/j.saa.2007.03.00917433764Search in Google Scholar

18. L. M. Pinto, L. F. Fraceto, M. H. Santana, T. A. Pertinhez, S. O. Junior and de E. Paula, Physico- -chemical characterization of benzocaine-beta-cyclodextrin inclusion complexes, J. Pharm. Biomed. Anal. 39 (2005) 956-963; DOI: 10.1016/j.jpba.2005.06.010.10.1016/j.jpba.2005.06.01016040222Search in Google Scholar

19. X. Ge, Z. Huang, S. L. Tian, Y. L. Huang and C. Z. Zeng, Complexation of carbendazim with hydroxypropyl-beta-cyclodextrin to improve solubility and fungicidal activity, Carbohyd. Polym. 89 (2012) 208-212; DOI: 10.1016/j.carbpol.2012.02.072.10.1016/j.carbpol.2012.02.07224750625Search in Google Scholar

20. P. Gornas, G. Neunert, K. Baczynski and K. Polewski, Beta-cyclodextrin complexes with chlorogenic and caffeic acids from coffee brew: Spectroscopic, thermodynamic and molecular modelling study, Food Chem. 114 (2009) 190-196; DOI: 10.1016/j.foodchem.2008.09.048.10.1016/j.foodchem.2008.09.048Search in Google Scholar

21. D. R. de Araujo, S. S. Tsuneda, C. M. S. Cereda, F. Del G. F. Carvalho, P. S. C. Preté, S. A. Fernandes, F. Yokaichiya, M. K. K. D. Franco, I. Mazzaro, L. F. Fraceto, A.de F. A. Braga and E. de Paula, Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta- -cyclodextrin inclusion complex, Eur. J. Pharm. Sci. 33 (2008) 60-71; DOI: 10.1016/j.ejps.2007. 09.010.Search in Google Scholar

22. P. Mura, E. Adragna, A. M. Rabasco, J. R. Moyano, J. I. Perez-Martinez, A. J. Arias and J. M. Gines, Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems, Drug Dev. Ind. Pharm. 25 (1999) 279-287; DOI: 10.1081/ DDC-100102172.10.1081/DDC-100102172Search in Google Scholar

23. E. E. M. Eid, A. B. Abdul, F. E. O. Suliman, M. A. Sukari, A. Rasedee and S. S. Fatah, Characterization of the inclusion complex of zerumbone with hydroxypropyl-beta-cyclodextrin, Carbohyd. Polym. 83 (2011) 1707-1714; DOI: 10.1016/j.carbpol.2010.10.033.10.1016/j.carbpol.2010.10.033Search in Google Scholar

24. Y. Y. Hwang, D. C. Shin, Y. S. Nam and B. K. Cho, Characterization, stability, and pharmacokinetics of sibutramine/beta-cyclodextrin inclusion complex, J. Ind. Eng. Chem. 18 (2012) 1412-1417; DOI: 10.1016/j.jiec.2012.01.046.10.1016/j.jiec.2012.01.046Search in Google Scholar

25. R. Yan, N. L. Ko, S. L. Li, Y. K. Tam and G. Lin, Pharmacokinetics and metabolism of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat, Drug Metab. Dispos. 36 (2008) 400-408; DOI: 10.1124/dmd.107.017707. 10.1124/dmd.107.01770718039808Search in Google Scholar